| scholarly article | Q13442814 |
| P356 | DOI | 10.1024/1661-8157/A002830 |
| P698 | PubMed publication ID | 29088964 |
| P2093 | author name string | Camillo Ribi | |
| Amélie Borgeat Kaeser | |||
| P2860 | cites work | Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes | Q24633568 |
| Seven steps to the diagnosis of NSAIDs hypersensitivity: how to apply a new classification in real practice? | Q28081823 | ||
| The natural history and clinical characteristics of aspirin-exacerbated respiratory disease | Q28194291 | ||
| Intranasal ketorolac challenge for the diagnosis of aspirin-exacerbated respiratory disease | Q28200319 | ||
| EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity | Q28211293 | ||
| The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges | Q28222887 | ||
| Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease | Q30410446 | ||
| Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease | Q33598927 | ||
| Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma | Q33905623 | ||
| African American Patients with Chronic Rhinosinusitis Have a Distinct Phenotype of Polyposis Associated with Increased Asthma Hospitalization. | Q33918154 | ||
| Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma | Q33921113 | ||
| Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature | Q34441715 | ||
| Rhinovirus infection induces interleukin-13 production from CD11b-positive, M2-polarized exudative macrophages | Q35207665 | ||
| Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with nasal polyps: a difference between aspirin-tolerant and aspirin-induced asthma? | Q37162102 | ||
| Aspirin induces IL-4 production: augmented IL-4 production in aspirin-exacerbated respiratory disease | Q42129014 | ||
| Concerning the nature of intolerance to aspirin | Q43723226 | ||
| Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis | Q44432091 | ||
| Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics | Q44675978 | ||
| The clinical dilemma of "silent desensitization" in aspirin-exacerbated respiratory disease | Q45390313 | ||
| Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis. | Q45986027 | ||
| Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease | Q46397188 | ||
| Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis | Q49046464 | ||
| Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma | Q49152600 | ||
| Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study. | Q51091863 | ||
| Treatment of aspirin exacerbated respiratory disease with a low salicylate diet: a pilot crossover study. | Q51688540 | ||
| Association of serum periostin with aspirin-exacerbated respiratory disease. | Q51709821 | ||
| Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin | Q70332893 | ||
| Aspirin, salicylate, sulfite and tartrazine induced bronchoconstriction. Safe doses and case definition in epidemiological studies | Q71749061 | ||
| Plasma acetylsalicylic acid and salicylic acid levels during aspirin provocation in aspirin-sensitive subjects | Q72486485 | ||
| P433 | issue | 22 | |
| P304 | page(s) | 1243-1249 | |
| P577 | publication date | 2017-01-01 | |
| P1433 | published in | Praxis | Q1684165 |
| P1476 | title | Le syndrome de Widal en pratique clinique | |
| P478 | volume | 106 |
Search more.